PRP treatment for lateral and medial epicondylitis
Current Clinical Recommendations and Applications for the Uses of Platelet Rich Plasma, NOVA Publications , ss.61-67, 2024
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2024
- Yayınevi: NOVA Publications
- Sayfa Sayıları: ss.61-67
- Anahtar Kelimeler: Injection, Lateral epicondylitis, Medial epicondylitis, Platelet-rich plasma
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Lateral epicondylitis (LE), also termed tennis elbow, is a tendonitis of the extensor carpi radialis brevis (ECRB) muscle. Involvement of the extensor carpi radialis longus and the extensor carpi ulnaris may also be observed. Its incidence in society is between 1% and 3% (Aksoy et al., 2022). Medial epicondylitis (ME), also known as golfer's elbow, occurs as a result of microtrauma and degeneration of the forearm flexor muscles at the common insertion point in the medial epicondyle of the elbow, which is similar to LE. It occurs between the fourth and sixth decades of life and affects both males and females equally (Amin et al., 2015). Elbow epicondylitis is associated with excessive use combined with repetitive wrist flexion, extension, supination, and pronation movements. There are many treatment options for lateral and medial epicondylitis. The first choice is usually conservative treatment, and success is often achieved (Lenoir et al., 2019; Tarpada et al., 2018). Commonly used treatments include rest, activity modification, nonsteroidal anti-inflammatory drugs (NSAIDs), physiotherapy, injections (corticosteroids, platelet-rich plasma, prolotherapy), and orthotics. Surgical treatment can also be implemented in resistant cases (Aktaş et al., 2014; Lenoir et al., 2019). Platelet-rich plasma (PRP) injections are frequently used in tendon and ligament pathologies. The efficacy of PRP therapy in the treatment of elbow epicondylitis has been proven in many studies in the literature. PRP is a safe and effective treatment method in cases where lateral and medial epicondylitis cannot be treated with first-line treatments.